Various retrospective studies have reported female sex, body mass index ≥ 25 kg/m2, biliary stent insertion, low pretreatment platelet count and UGT1A1 genetic polymorphisms as risk factors for FN in Asian PC patients treated with FOLFIRINOX [13, 14]. Here, UGT1A1 is linked to pachyonychia congenita.